The Department of Health and Social Care publishes statistics on medicine supply disruption across the UK, and it is a standing feature of the system rather than an occasional crisis. Weight-loss medicines have had a particularly turbulent few years, with demand repeatedly outrunning manufacturing.
The UK has already seen this play out visibly: patients unable to obtain Mounjaro before the 2025 list price rise, the manufacturer asking distributors to stop taking pharmacy orders over stockpiling concerns, and pharmacies prioritising existing patients over new starts.
Why It Happens
- Manufacturing capacity. Injectable peptide medicines in pre-filled pens are complex to make, and capacity cannot be added quickly.
- Demand spikes, including from anticipated price changes.
- Strength-specific shortages. One dose in the ladder can be unavailable while others are fine — which is a particular problem when you need the next step up.
- Allocation. When supply is tight, manufacturers allocate to wholesalers, who allocate to pharmacies. Smaller providers can be squeezed hardest.
What It Means for Price Comparison
A listed price is only useful if the pharmacy can supply. This is why a very cheap price at an unfamiliar provider deserves a check: is that strength actually in stock, and what is their track record on continuity?
It is also why the cheapest option for month one can be a poor choice overall. Running out mid-course is not merely inconvenient — an interruption long enough usually means dropping back down the escalation and re-climbing, which costs both time and money.
If Your Dose Is Unavailable
- Contact your prescriber early, not on the day you run out. There are more options with two weeks' notice than with none.
- Ask what the alternatives are. Depending on the medicine and the shortage, options might include a different presentation, a different strength combination, or a different medicine entirely.
- Ask specifically about restarting. If you do have a gap, whether you resume at your current dose or step back down is a clinical decision that depends on how long the gap was.
- Check other registered pharmacies. Stock varies between suppliers, and moving your prescription is legitimate.
- Do not fill the gap from an unregulated source. This is precisely the scenario the counterfeit market feeds on, and the MHRA has documented falsified pens reaching patients even through legitimate channels.
What Not to Do
- Do not stockpile. It is a collective action problem: hoarding is a large part of why shortages get worse, and these medicines have storage requirements that casual stockpiling tends to breach.
- Do not split or stretch doses to make a pen last longer without clinical advice. Dose accuracy in these devices is not something to improvise with.
- Do not buy from a marketplace or social media seller. The MHRA has seized substantial quantities of falsified weight-loss pens, some of which appear to have contained insulin.
The Realistic Expectation
Anyone planning a multi-month course should assume at least one supply wobble along the way, and choose a provider partly on whether they communicate well when it happens. Price matters. So does whether someone answers when the pen you need is not there.